By Canadian Press

Health Canada approves Pfizer’s updated COVID-19 vaccine, manufacturer says

Sep 24, 2024 | 9:13 AM

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.

The Pfizer-BioNTech mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.

Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current vaccine will be used during this fall’s respiratory virus season.

Comirnaty is the third updated COVID-19 vaccine approved by Health Canada for this season, following its authorization of Moderna’s Spikevax mRNA vaccine and Novavax’s protein-based vaccine, Nuvaxovid, last week.

Both the Pfizer and Moderna vaccines are approved for adults and for children six months of age and older.

The Tattle of Hastings

THE TATTLE OF HASTINGS: Athletic therapist Kuresh talks trailblazing in the WHL, NHL dreams

14h ago

Question of the Week

Have you made changes to your holiday shopping or travel plans because of rising costs?

Nov 18, 2024

One Man's Opinion

COLLINS: The icon who is Taylor Swift

Nov 17, 2024

Novavax is approved for adults and for children 12 years and older.

This report by The Canadian Press was first published Sept. 24, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

Nicole Ireland and Hannah Alberga, The Canadian Press